author-photo

Ann L. White

University of Southampton

13

Papers

638

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity.

2020 Cancer Cell
Show All
- Source
- Cite
- Save
Citations (13)
Complex Interplay between Epitope Specificity and Isotype Dictates the Biological Activity of Anti-human CD40 Antibodies

2018 Cancer Cell
Show All
- Source
- Cite
- Save
Citations (49)
Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies

2015 Cancer Cell
Show All
- Source
- Cite
- Save
Citations (102)
Abstract IA06: Designing immunostimulatory antibodies for cancer treatment

2015 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
The Use of Anti-CD40 mAb in Cancer

2014 Current Topics in Microbiology and Immunology
Show All
- Source
- Cite
- Save
Citations (18)
FcγRIIB as a key determinant of agonistic antibody efficacy.

2014 Current Topics in Microbiology and Immunology
Show All
- Source
- Cite
- Save
Citations (20)
Fcγ Receptor Dependency of Agonistic CD40 Antibody in Lymphoma Therapy Can Be Overcome through Antibody Multimerization

2014 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (43)
FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs

2013 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (33)
CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses

2008 European Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (90)